Addressing Mental Health Issues In HIV Care
The integration of mental health interventions into HIV prevention and treatment platforms can reduce the opportunity costs of care and improve treatment outcomes, argues a new Policy Forum article published in this week's PLOS Medicine...
News From Annals Of Internal Medicine, May 21, 2013
1. Older, Sicker Men Unlikely to Benefit from Aggressive Therapy for Newly Diagnosed Prostate Cancer Older men with localized prostate cancer and other serious health conditions may not benefit from aggressive treatment for their cancer...
HIV-Testing In Emergency Departments Can Be Increased Through Peer-Referral Programs
Researchers at the University of Cincinnati (UC) have found that incorporating a peer-referral program for HIV testing into emergency departments can reach new groups of high-risk patients and brings more patients into the hospital for testing...
New Tool Can Identify Powerful HIV Antibodies, Could Speed HIV Vaccine Research
A team of NIH scientists has developed a new tool to identify broadly neutralizing antibodies (bNAbs) capable of preventing infection by the majority of HIV strains found around the globe, an advance that could help speed HIV vaccine research...
Mathematical Model Measures Hidden HIV Virus Replication
Scientists have long believed that measuring the amount of HIV in a person's blood is an indicator of whether the virus is actively reproducing. A University of Delaware-led research team reports new evidence that hidden virus replication may be occurring within the body's tissue, despite undetectable virus levels in the blood...
Are Much Needed Health Interventions Reaching Women And Children Across The Developing World?
Measuring coverage of maternal, newborn and child health in low- and middle-income countries is critical to ensuring that health interventions are reaching the women and children who need them most, says a new Collection of articles published by PLOS this week...
SUSTIVA® (Efavirenz) Receives US FDA SNDA Approval For Use In HIV-1 Infected Pediatric Patients
Approval offers a once-daily option as part of a regimen for HIV-1 infected infants as young as three months and weighing at least 3.5 kg. "Capsule sprinkle" administration allows dosing in patients who cannot swallow capsules or tablets. Bristol-Myers Squibb Company have announced that the U.S...
In HIV Vaccine Trial In Thailand, Competing Antibodies May Have Limited The Protection Achieved
Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people...
Researchers Have Discovered Synthetic Agents Used To Treat HIV Inflammation
HIV can cause serious inflammation, regardless of drug therapy, as it develops slowly in immune cells called macrophages...
Synthetic Agents Related To Active Ingredient In Marijuana Weaken HIV Infection
HIV, the virus that causes AIDS, is notorious for hiding within certain types of cells, where it reproduces at a slowed rate and eventually gives rise to chronic inflammation, despite drug therapy...
Compounds That Stimulate The Cannabinoid Type 2 Receptor In White Blood Cells Can Weaken HIV-1 Infection
A new use for compounds related in composition to the active ingredient in marijuana may be on the horizon: a new research report published in the Journal of Leukocyte Biology shows that compounds that stimulate the cannabinoid type 2 (CB2) receptor in white blood cells, specifically macrophages, appear to weaken HIV-1 infection...
All Adults, Adolescents, And Pregnant Women Should Be Screened For HIV
New recommendations from the United States Preventive Services Task Force (USPSTF) urge physicians to screen all adults and adolescents aged 15 - 65 for HIV. In addition, all pregnant women should receive screening, even those who are in labor but have not yet been screened. Rapid screening tests and conventional tests are considered equally accurate for screening...
Everyone Aged 15 To 65 Should Receive HIV Testing, New Guidelines Say
Clinicians are now recommended to screen all patients aged 15 to 65, and other teens or older adults who are at an elevated risk for HIV infection, according to new guidelines released today. The guidelines were part of the final recommendation statement on screening for HIV by the U.S...
Latest HIV Vaccine Fails In The US, Government Stops Study
A study testing the latest experimental HIV vaccine has been stopped after an independent review board found that it did not prevent HIV infection and did not decrease the amount of HIV in the blood. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, announced that they will stop giving doses of this experimental vaccine...
Highly Active Antiretroviral Therapies May Be Cardioprotective In HIV-Infected Children, Teens
Long-term use of highly active antiretroviral therapies (HAART) does not appear to be associated with impaired heart function in children and adolescents in a study that sought to determine the cardiac effects of prolonged exposure to HAART on children infected with the human immunodeficiency virus (HIV), according to a report published Online First by JAMA Pediatrics, a JAMA Network publication...